Related Experiment Video
Updated: Oct 14, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Pulmonary Infections, Including Ventilator-Associated Pneumonia
1Administrative NP, Jackson Pulmonary Associates, Jackson, 971 Lakeland Drive, Suite 1052, Jackson, MS 39216, USA.
Pneumonia treatment guidelines from 2016 and 2017 emphasize timely antibiotic selection based on pathogens and resistance. Adhering to evidence-based strategies is crucial for reducing pneumonia
Area of Science:
- Pulmonology
- Infectious Diseases
- Clinical Medicine
Background:
- Pneumonia is a significant cause of illness, death, and hospitalization.
- Current treatment strategies are informed by established guidelines.
Purpose of the Study:
- To review and synthesize current international guidelines for pneumonia management.
- To highlight the importance of pathogen-specific and resistance-informed antibiotic selection.
- To underscore the role of evidence-based strategies in improving patient outcomes and reducing mortality risk.
Main Methods:
- Review of guidelines from the American Thoracic Society, Infectious Diseases Society of America (2016), and an International European task force (2017).
- Analysis of recommendations concerning antibiotic selection based on causative pathogens, drug resistance, and mortality risk.
Main Results:
- Guidelines provide specific recommendations for antibiotic selection in pneumonia.
- Consideration of drug resistance and mortality risk is integral to European guidelines.
- Timely and appropriate treatment is essential for patient outcomes.
Conclusions:
- Effective pneumonia management requires adherence to evidence-based guidelines.
- Antibiotic selection should be guided by causative pathogens, resistance patterns, and patient risk factors.
- Implementing guideline-recommended strategies can reduce pneumonia-related morbidity, mortality, and hospitalizations.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Pneumonia II: Pathophysiology